Generation of E3-deleted canine adenovirus type 2 expressing the Gc glycoprotein of Seoul virus by gene insertion or deletion of related terminal region sequences

Journal of General Virology

Volumn 91, Issue 7, 2010, Pages 1764-1771

  Yuan, Zi Guo ^a,b   Luo, Sheng Jun ^c   Xu, Hui Juan ^d   Wang, Xiao Hu ^b   Li, Juan ^a   Yuan, Li Guo ^a   He, Le Tian ^a   Zhang, Xiu Xiang ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c INSTITUTE OF ANIMAL SCIENCE   (China)

^d GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GC; UNCLASSIFIED DRUG; VIRUS VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CANINE ADENOVIRUS; CONTROLLED STUDY; GENE DELETION; GENE INSERTION; GENE SEQUENCE; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; VIRUS ENVELOPE; VIRUS STRAIN; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; DOG; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; SEOUL VIRUS;

CANINE ADENOVIRUS TYPE 2; HANTAVIRUS; MUS; SEOUL VIRUS;

ADENOVIRUS E3 PROTEINS; ADENOVIRUSES, CANINE; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; DOGS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, VIRAL; GLYCOPROTEINS; MICE; MICE, INBRED BALB C; SEOUL VIRUS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 77954164751     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.018473-0     Document Type: Article

References (39)

1. Araki, K., Yoshimatsu, K., Ogino, M., Ebihara, H., Lundkvist, A., Kariwa, H., Takashima, I. & Arikawa, J. (2001). Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections. J Clin Microbiol 39, 2397-2404.
2. Asada, H., Balachandra, K., Tamura, M., Kondo, K. & Yamanishi, K. (1989). Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. J Gen Virol 70, 819-825. (Pubitemid 19099632)
3. Bett, A. J., Prevec, L. & Graham, F. L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 67, 5911-5921. (Pubitemid 23277501)
4. Bharadwaj, M., Lyons, C. R., Wortman, I. A. & Hjelle, B. (1999). Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 17, 2836-2843.
5. Bounous, D. I., Campagnoli, R. P. & Brown, J. (1992). Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 36, 1022-1027.
6. Christensen, J., Alexandersen, S., Bloch, B., Aasted, B. & Uttenthal, A. (1994). Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink. J Gen Virol 75, 149-155. (Pubitemid 24033991)
7. Elliott, R. M. (1990). Molecular biology of Bunyaviridae. J Gen Virol 71, 501-522.
8. Fan, Q. S., Xia, X. Z., Gao, Y. W. & Huang, G. (1982). Attenuation SY strain of CAV-2 strain. Chin J Vet 35, 7-9 (in Chinese).
9. Ferreira, T. B., Alves, P. M., Aunins, J. G. & Carrondo, M. J. T. (2005). Use of adenoviral vectors as veterinary vaccines. Gene Ther 12, S73-S83.
10. Geldmacher, A., Skrastina, D., Petrovskis, I., Borisova, G., Berriman, J. A., Roseman, A. M., Crowther, R. A., Fischer, J., Musema, S. & other authors (2004). An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice. Virology 323, 108-119.
11. Hong, W., Xiao, S., Zhou, R., Fang, L., He, Q., Wu, B., Zhou, F. & Chen, H. (2002). Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 20, 1205-1214.
12. Hooper, J. W., Kamrud, K. I., Elgh, F., Custer, D. & Schmaljohn, C. S. (1999). DNA vaccine with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 255, 269-278.
13. Hooper, J. W., Custer, D. M., Thompson, E. & Schmaljohn, C. S. (2001). DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J Virol 75, 8469-8477.
14. Hu, R., Zhang, S., Fooks, A. R., Yuan, H., Liu, Y., Li, H., Tu, C., Xia, X. & Xiao, Y. (2006). Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Microbes Infect 8, 1090-1097.
15. Hu, R. L., Liu, Y., Zhang, S. F., Zhang, F. & Fooks, A. R. (2007). Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Vaccine 25, 5301-5307.
16. Jonsson, C. B. & Schmaljohn, C. S. (2001). Replication of hantaviruses. Curr Top Microbiol Immunol 256, 15-32.
17. Kariwa, H., Yoshimatsu, K. & Arikawa, J. (2007). Hantavirus infection in East Asia. Comp Immunol Microbiol Infect Dis 30, 341-356.
18. Langeveld, J. P., Casal, J. I., Cortes, E., van de Wetering, G., Boshuizen, R. S., Schaaper, W. M., Dalsgaard, K. & Meloen, R. H. (1994). Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12, 1473-1480.
19. Li, J., Faber, M., Papaneri, A., Faber, M. L., McGettigan, J. P., Schnell, M. J. & Dietzschold, B. (2006). A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Virology 356, 147-154.
20. Morrison, M. D., Reid, D., Onions, D., Spibey, N. & Nicolson, L. (2002). Generation of E3-deleted canine adenoviruses expressing canine parvovirus capsid by homologous recombination in bacteria. Virology 293, 26-30.
21. Randrianarison-Jewtoukoff, V. & Perricaudet, M. (1995). Recombinant adenoviruses as vaccines. Biologicals 23, 145-157.
22. Reed, L. J. & Münch, R. H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493-497.
23. Reid, S.M., Ferris, N. P., Hutchings, G. H., De Clercq, K., Newman, B. J., Knowl, N. J. & Samuel, A. R. (2001). Diagnosis of foot-and-mouth disease by RT-PCR: use of phylogenetic data to evaluate primers for the typing of viral RNA in clinical samples. Arch Virol 146, 2421-2434.
24. Schmaljohn, C. & Hjelle, B. (1997). Hantaviruses: a global disease problem. Emerg Infect Dis 3, 95-104.
25. Schmaljohn, C. S. & Le Duc, J. W. (1998). Bunyaviridae. In Topley and Wilson's Microbiology and Microbial Infections, 9th edn, pp. 601-628. Edited by L. H. Collier, A. Balows & M. Sussman. London: M. Arnold.
26. Schmaljohn, C. S., Chu, Y. K., Schmaljohn, A. L. & Dalrymple, J. M. (1990). Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 64, 3162-3170. (Pubitemid 20219517)
27. Schmidt, N. J., Lennette, E. H. & King, C. J. (1966). Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections. J Immunol 97, 64-74.
28. Shenk, T. (1996). Adenoviruses. In Fields Virology, 3rd edn, pp. 2111- 2148. Philadelphia, PA: Lippincott-Raven.
29. Tham, K. M., Horner, G. W. & Hunter, R. (1998). Isolation and identification of canine adenovirus type-2 from the upper respiratory tract of a dog. N Z Vet J 46, 102-105.
30. Wichmann, D., Grone, H. J., Frese, M., Pavlovic, J., Anheier, B., Haller, O., Klenk, H. D. & Feldmann, H. (2002). Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice. J Virol 76, 8890-8899.
31. Xia, X. Z., Fang, Q. S. & Huang, G. (2000). Isolation and identification of a canine adenovirus avirulent strain. Chin J Vet Med 34, 1-4 (in Chinese).
32. Xiao, S., Chen, H., Fang, L., Liu, C., Zhang, H., Jiang, Y. & Hong, W. (2004). Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22, 345-351.
33. Xu, Z. Z., Hyatt, A., Boyle, D. B. & Both, G. W. (1997). Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. Virology 230, 62-71.
34. Yamamoto, T. (1966). Some physical and growth characteristics of a canine adenovirus isolated from dogs with laryngotracheitis. Can J Microbiol 12, 303-311.
35. Yuan, Z., Zhang, X., Zhang, S., Xu, H., Wang, X. & Hu, R. (2008). Study on high-level expression of hantavirus S gene in prokaryocyte. Chin J Vector Bio & Control 19, 237-240 (in Chinese).
36. Yuan, Z. G., Li, X. M., Mahmmod, Y. S., Wang, X. H., Xu, H. J. & Zhang, X. X. (2009). A single immunization with a recombinant canine adenovirus type 2 expressing the Seoul virus Gn glycoprotein confers protective immunity against Seoul virus in mice. Vaccine 27, 5247-5251.
37. Zakhartchouk, A. N., Reddy, P. S., Baxi, M., Baca-Estrada, M. E., Mehtali, M., Babiuk, L. A. & Tikoo, S. K. (1998). Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full length and truncated form of bovine herpesvirus type 1 glycoprotein gD. Virology 250, 220-229.
38. Zhang, S. F., Hu, R. L., Niu, J. Q. & Xia, X. Z. (2002). Cloning and identification of the full length infectious genome of canine adenovirus type-2. Chin J Vet Sci 22, 533-535 (in Chinese).
39. Zhang, S., Liu, Y., Fooks, A. R., Zhang, F. & Hu, R. (2008). Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Vaccine 26, 345-350.